|
Market Closed -
Hong Kong S.E.
04:08:26 2026-10-14 EDT
|
5-day change | 1st Jan Change | ||
| 21.32 HKD | +1.43% |
|
+2.60% | -30.05% |
| 09-24 | Medtide Acquires China Land, Property for Peptide CDMO Project | MT |
| 09-24 | Medtide Inc. Announces Resignation of Li Lingmei as Executive Director, Effective September 24, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 380M | - | - | |||
| 70.44B | |||||
| 50.31B | |||||
| 47.51B | |||||
| 42.91B | |||||
| 40.39B | - | - | - | - | - |
- Stock Market
- Stocks
- 3880 Stock
- Charts Medtide Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
